Croucher Kristina M, Fleming Sheila M
Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH, United States.
Biomedical Sciences Graduate Program, Kent State University, Kent, OH, United States.
Front Neurol. 2024 Jan 5;14:1252400. doi: 10.3389/fneur.2023.1252400. eCollection 2023.
ATP13A2 is a lysosomal protein involved in polyamine transport with loss of function mutations associated with multiple neurodegenerative conditions. These include early onset Parkinson's disease, Kufor-Rakeb Syndrome, neuronal ceroid lipofuscinosis, hereditary spastic paraplegia, and amyotrophic lateral sclerosis. While mutations may result in clinical heterogeneity, the basal ganglia appear to be impacted in the majority of cases. The basal ganglia is particularly vulnerable to environmental exposures such as heavy metals, pesticides, and industrial agents which are also established risk factors for many neurodegenerative conditions. Not surprisingly then, impaired function of ATP13A2 has been linked to heavy metal toxicity including manganese, iron, and zinc. This review discusses the role of ATP13A2 in basal ganglia function and dysfunction, potential common pathological mechanisms in ATP13A2-related disorders, and how gene x environment interactions may contribute to basal ganglia dysfunction.
ATP13A2是一种参与多胺转运的溶酶体蛋白,其功能丧失突变与多种神经退行性疾病相关。这些疾病包括早发性帕金森病、库福-拉凯布综合征、神经元蜡样脂褐质沉积症、遗传性痉挛性截瘫和肌萎缩侧索硬化症。虽然突变可能导致临床异质性,但在大多数病例中基底神经节似乎受到影响。基底神经节特别容易受到环境暴露的影响,如重金属、农药和工业制剂,这些也是许多神经退行性疾病的确立危险因素。因此,毫不奇怪,ATP13A2功能受损与包括锰、铁和锌在内的重金属毒性有关。本综述讨论了ATP13A2在基底神经节功能和功能障碍中的作用、ATP13A2相关疾病中潜在的共同病理机制,以及基因与环境相互作用如何导致基底神经节功能障碍。